Why Iovance Stock Leaped 17% Higher Today
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-06-03 22:52:31

Investors often get excited when top officials at a company pile into shares of their business. So it was on Friday with Iovance Biotherapeutics (IOVA 18.94%). A flurry of insider buying led to plenty of outsider buying on the market, and pushed the stock's price 17% higher on the day.
So what
As revealed by Securities and Exchange Commission filings dated Thursday, everyone who is anyone at Iovance, it seems, was hitting the buy button.

Image source: Getty Images.

Wayne Rothbaum, a member of the biotech company's board of directors and the president of healthcare sector investment fund Quogue Capital, disclosed two recent purchases of 500,000 shares of Iovance's common stock.
